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Abstract
Background:  Helicobacter  pylori  causes  motor,  secretory,  and  inﬂammatory  gastrointestinal
disorders  and  therefore  the  term  ‘‘functional’’  has  been  questioned  when  referring  to  dyspepsia
associated  with  this  bacterium.  Patients  with  dyspepsia  and  Helicobacter  pylori  infection  could
have clinical  characteristics  that  differentiate  them  a  priori  from  those  with  true  functional
dyspepsia.
Aims: To  determine  whether  there  are  clinical  differences  between  patients  with  functional
dyspepsia  and  Helicobacter  pylori-associated  dyspepsia  that  enable  their  a  priori  identiﬁca-
tion and  to  know  the  prevalence  of  Helicobacter  pylori  infection  in  patients  with  functional
dyspepsia.
Patients and  methods:  A  total  of  578  patients  with  dyspepsia  with  no  signiﬁcant  lesions
detectable  through  endoscopy  were  divided  into  2  groups  according  to  the  presence  of  Heli-
cobacter pylori.  The  clinical  characteristics,  medical  history,  comorbidities,  and  use  of  health
resources  were  compared  between  the  two  groups.  A  sub-analysis  pairing  the  groups  by  age  and
sex in  a  1:1  ratio  was  carried  out  to  reduce  bias.
Results:  A  total  of  336  patients  infected  with  Helicobacter  pylori  were  compared  with  242  non-
infected patients.  The  prevalence  of  infection  in  the  patients  with  dyspeptic  symptoms  and  no
endoscopically  detectable  lesions  was  58%.  The  initial  analysis  showed  that  the  cases  with Please cite this article as: Rodríguez-García JL, Carmona-Sánchez R. Dispepsia funcional y dispepsia asociada a infección por Helicobacter
ylori: ¿son entidades con características clínicas diferentes? Revista de Gastroenterología de México. 2016;82:126--133.
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dyspepsia  and  Helicobacter  pylori  infection  were  more  frequently  associated  with  overweight,
obesity,  high  blood  pressure,  diabetes  mellitus,  and  metabolic  syndrome,  but  the  paired  analysis
nulliﬁed  all  these  differences.
Conclusions:  The  patients  with  dyspepsia  infected  with  Helicobacter  pylori  had  similar  clini-
cal characteristics  to  the  non-infected  patients  and  could  not  be  differentiated  a  priori.  The
prevalence  of  Helicobacter  pylori  infection  in  patients  with  functional  dyspepsia  was  58%  and
increased  with  age.
©  2016  Asociacio´n  Mexicana  de  Gastroenterolog´ıa.  Published  by  Masson  Doyma  Me´xico  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Dispepsia  funcional  y  dispepsia  asociada  a  infección  por  Helicobacter  pylori: ¿son
entidades  con  características  clínicas  diferentes?
Resumen
Antecedentes:  El  Helicobacter  pylori  (Hp)  causa  trastornos  motores,  secretores  e  inﬂamatorios
gastrointestinales  por  lo  que  el  término  «funcional» ha  sido  puesto  en  duda  cuando  se  reﬁere
a dispepsia  asociada  a  la  bacteria.  Los  enfermos  con  dispepsia  infectados  por  Hp  podrían  tener
características  clínicas  que  podrían  diferenciarlos  a  priori  de  los  funcionales.
Objetivos:  Determinar  si  existen  diferencias  clínicas  entre  los  pacientes  con  dispepsia  funcional
(DF) y  dispepsia  asociada  a  Hp  que  permitan  identiﬁcarlos  a  priori  y  conocer  la  prevalencia  de
infección  por  Hp  en  pacientes  con  DF.
Pacientes  y  métodos:  Quinientos  setenta  y  ocho  pacientes  con  dispepsia  sin  lesiones  signiﬁca-
tivas detectables  por  endoscopia  fueron  divididos  en  2  grupos  de  acuerdo  con  la  presencia  de
Hp. Se  compararon  las  características  clínicas,  los  antecedentes  médicos,  las  comorbilidades  y
el uso  de  recursos  de  salud  entre  ambos  grupos.  Se  realizó  un  subanálisis  pareando  los  grupos
por edad  y  sexo  en  proporción  1:1  para  reducir  el  efecto  de  sesgos.
Resultados:  Se  comparó  a  336  infectados  por  Hp  y  242  no  infectados.  La  prevalencia  de  la
infección en  pacientes  con  síntomas  dispépticos  sin  lesiones  detectables  por  endoscopia  fue
del 58%.  El  análisis  inicial  mostró  que  los  casos  con  dispepsia  infectados  por  Hp  se  asociaron  con
mayor frecuencia  a  sobrepeso,  obesidad,  hipertensión  arterial,  diabetes  mellitus  y  síndrome
metabólico,  pero  el  análisis  pareado  anuló  todas  estas  diferencias.
Conclusiones:  Los  pacientes  con  dispepsia  infectados  por  Hp  muestran  características  clínicas
similares a  los  no  infectados  y  no  pueden  ser  diferenciados  a  priori.  La  prevalencia  de  infección
por Hp  en  pacientes  con  DF  es  del  58%  y  se  incrementa  con  la  edad.
© 2016  Asociacio´n  Mexicana  de  Gastroenterolog´ıa.  Publicado  por  Masson  Doyma  Me´xico  S.A.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Dyspepsia  is  one  of  the  most  common  digestive  syndromes
in  the  general  population  and  is  deﬁned  as  the  presence
of  discomfort  or  chronic  and  recurrent  pain  in  the  upper
abdomen.1 It  has  been  described  as  a  negative  sensation
that  can  incorporate  a  wide  variety  of  symptoms  including
bloating,  early  satiety,  fullness,  burping,  nausea,  or  con-
tinuous  or  intermittent  vomiting.2 This  set  of  symptoms
can  be  the  manifestation  of  different  organic,  systemic,  or
metabolic  diseases  (organic  dyspepsia)  or  it  may  have  no
evident  cause  (functional  dyspepsia  [FD]).  Thus,  dyspepsia
encompasses  a  heterogeneous  group  of  diseases  whose  clini-
cal  manifestations  are  common,  but  are  caused  by  different
pathophysiologic  mechanisms.3
Helicobacter  pylori  (Hp)  is  the  most  frequent  cause  of
chronic  bacterial  infection  in  humans.4 Its  prevalence  varies
i
b
t
brom  20  to  90%,  depending  on  conditions  of  development
nd  hygiene.5 Its  prevalence  is  very  high  in  Mexico  and
n  other  Latin  American  countries  with  similar  sociodemo-
raphic  characteristics.6 The  reported  prevalence  of  Hp
nfection  in  patients  with  FD  varies  from  30  to  70%.7
It  is  known  that  Hp  can  cause  dyspeptic  symptoms,
nducing  motor  disorders,  causing  visceral  hypersensitivity,
cid  secretion  alterations,  active  and  persistent  inﬂam-
ation,  and  post-infectious  changes  in  the  gastroduodenal
ucosa.8,9 By  deﬁnition,  functional  gastrointestinal  disor-
ers  are  characterized  by  the  absence  of  organic,  metabolic,
r  systemic  diseases  that  explain  their  symptoms.  One
otable  exception  to  this  rule  is  Hp  infection  that  is  included
n  FD  according  to  the  Rome  III  criteria.10 Given  that  the
acterium  can  directly  or  indirectly  cause  motor,  secre-
ory,  and  inﬂammatory  disorders,  the  term  ‘‘functional’’  has
een  questioned  in  regard  to  dyspepsia  associated  with  Hp
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D-Hp).11 Knowing  the  clinical  characteristics  of  the  patients
ith  dyspepsia  infected  with  the  bacterium  and  those  with-
ut  the  infection  would  enable  us  to  deﬁne  the  groups  that
ould  beneﬁt  from  distinct  treatments.
The  primary  aim  of  this  work  was  to  determine  whether
here  are  clinical  differences  between  the  patients  with  FD
nd  D-Hp  that  enable  its  identiﬁcation  a  priori. The  sec-
ndary  aim  was  to  know  the  prevalence  of  Hp  infection  in
atients  with  FD.
atients and  methods
ll  the  patients  seen  for  dyspepsia  that  underwent  ﬁrst-time
pper  gastrointestinal  endoscopy  within  the  time  frame  of
pril  2006  and  August  2015  were  considered  for  participa-
ion  in  this  study.  Dyspepsia  was  deﬁned  as  the  presence  of
hronic  and  recurrent  discomfort  in  the  upper  abdomen  that
ncluded  one  or  more  of  the  following  symptoms:  epigastric
ain  or  burning  sensation,  early  satiety,  fullness,  burping,
loating,  nausea,  or  vomiting.2
A  complete  and  uniform  anamnesis  was  carried  out  and
he  same  physician  (RCS)  transferred  all  the  information  to
n  electronic  format  with  pre-established  text  ﬁelds.  The
ame  endoscopist  (RCS)  also  performed  all  the  endoscopic
tudies  at  the  same  endoscopy  unit  of  a  single  hospital  cen-
er.  Two  biopsies  were  taken  from  the  stomach  (one  from
he  body  and  one  from  the  antrum)  in  all  of  the  cases  for
he  rapid  urease  test  (Azutim®,  Innovare  R&D,  Mexico  City,
exico).  Registration  (photos  and  video)  of  the  endoscopic
xamination  was  obtained  and  a  structured  report  stipulated
he  ﬁndings  and  the  deﬁnitive  diagnosis.  For  the  purpose  of
his  study,  endoscopic  ﬁndings,  such  as  gastric  mucosa  with
rythema,  pale  areas,  nodularity,  reticular  pattern,  or  vas-
ular  pattern  visualization,  were  considered  normal  in  the
bsence  of  erosive,  ulcerated,  or  neoplastic  lesions.
Those  patients  presenting  with  heartburn  and  regurgi-
ation  as  the  only  symptoms  or  the  predominant  ones  or
ith  abdominal  pain  that  improved  after  a  bowel  move-
ent,  were  excluded  from  the  study.  All  patients  with  alarm
ymptoms  or  suspicion  of  organic  disease,  such  as  dyspha-
ia,  signiﬁcant  involuntary  weight  loss  (>  10%  of  the  habitual
eight  within  the  last  6  months),  anemia,  gastrointesti-
al  bleeding  in  any  clinical  presentation,  those  patients  in
hom  endoscopy  or  biopsy  was  contraindicated,  patients
hat  had  taken  acid  secretion  inhibitors  or  antibiotics  in  the
 weeks  prior  to  endoscopy,  and  those  that  had  any  type  of
sophageal,  gastric,  or  duodenal  surgery  were  also  excluded
rom  the  study.
All patients  in  whom  erosions,  ulcers,  or  neoplasia  in
ny  portion  of  the  esophagus,  stomach,  or  duodenum  were
etected,  were  eliminated  from  the  study.  Patients  with
iminutive  gastric  polyps  (fewer  than  5  and  smaller  than
 mm)  were  included  in  the  study,  as  long  as  they  did  not
resent  with  mucosal  lesions.  All  patients  that  did  not  have
 complete  clinical  case  record  were  also  eliminated  from
he  study.
Two  groups  were  formed  in  accordance  with  the  result
f  the  rapid  urease  test:  those  patients  with  dyspepsia  that
ad  Hp  infection  (Hp  group)  and  those  with  dyspepsia  and
o  Hp  infection  (non-Hp  group).  The  following  clinical  char-
cteristics  were  compared  between  the  two  groups:  sex,
s
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ge,  a  family  history  of  organic  and  functional  gastrointesti-
al  diseases,  smoking,  alcohol  consumption,  a  past  history
f  abdominal  or  esthetic  surgeries,  and  a  history  of  aller-
ies.  Hospital  admissions  and  emergency  department  visits
ere  also  registered,  along  with  psychiatric  attention  and
he  use  of  psychotropic  drugs  during  the  year  prior  to  the
ndoscopic  study.  Finally,  body  mass  index,  the  frequency
f  concomitant  diseases,  and  drug  use  at  the  time  of  the
ndoscopy  were  compared  between  the  groups.  The  World
ealth  Organization’s  deﬁnition  of  metabolic  syndrome  was
tilized.12
According  to  the  set  of  predominant  dyspeptic  symptoms
t  the  time  of  evaluation,  the  patients  were  classiﬁed  as  hav-
ng  epigastric  pain  syndrome  if  they  presented  with  pain  or
urning  sensation  or  both  in  the  upper  abdomen  and  as  hav-
ng  postprandial  distress  syndrome  if  they  presented  with
arly  satiety  or  fullness  or  both.  Those  patients  that  had
ll  the  symptoms,  none  of  which  was  predominant,  were
lassiﬁed  as  having  overlap  syndrome.
tatistical analysis
he  clinical  data  were  obtained  from  the  case  record  and
ndoscopic  report  and  recorded  on  a  data  collection  sheet
nd  placed  in  a  database  (Excel,  Microsoft).  The  descriptive
ata  were  expressed  as  percentages,  means,  and  ranges.
he  chi-square  test  and  Fisher’s  exact  test  were  used  for
he  comparative  analysis  and  were  calculated  utilizing  the
pi  Info  application  for  the  iPad  (Epi  InfoTM version  2.0.2.
enters  for  Disease  Control  and  Prevention,  Atlanta,  GA,
SA).  All  p  values  above  0.05  were  not  considered  signiﬁ-
ant.  The  odds  ratio  (OR)  and  95%  conﬁdence  interval  were
lso  calculated  when  deemed  necessary.  In order  to  prevent
he  inﬂuence  of  selection  bias  on  some  of  the  factors,  a  sub-
nalysis  was  carried  out  pairing  the  groups  by  age  and  sex  at
 1:1  ratio.  Two  hundred  and  ﬁfteen  subjects  were  included
n  each  group  for  this  sub-analysis.
esults
 total  of  1038  patients  with  no  prior  endoscopic  evaluation
ere  seen  for  dyspeptic  symptoms  during  the  study  period.
hree  hundred  and  seven  patients  were  excluded  (198  for
resenting  with  heartburn  and  acid  regurgitation  as  predom-
nant  symptoms,  96  for  presenting  with  an  alarm  symptom
r  sign  of  organic  disease,  and  13  for  esophageal,  gastric,
r  duodenal  surgery).  One  hundred  and  ﬁfty-three  patients
ere  eliminated  (85  for  detection  of  erosions,  ulcers,  or  neo-
lasias  and  68  for  having  incomplete  clinical  case  records).
A  total  of  578  patients  with  dyspepsia  and  no  signiﬁ-
ant  lesions  detected  at  endoscopy  were  included  in  the
nal  analysis:  336  cases  infected  with  Hp  (Hp  group)  and
42  cases  without  the  infection  (non-Hp  group),  resulting
n  a  58.1%  prevalence  of  infection  with  the  bacterium  in
atients  with  dyspeptic  symptoms  and  no  signiﬁcant  lesions
etected  at  endoscopy.  A  similar  number  of  patients  in
oth  groups  were  studied  for  treatment-refractory  dyspep-
ia  (76.2%  infected  with  Hp  vs  77.5%  without  Hp,  p  = NS),
hereas  the  rest  had  unstudied  dyspepsia  (23.8%  infected
ith  Hp  vs  22.3%  without  Hp,  p  =  NS).  The  mean  progression
ime  of  the  dyspeptic  symptoms  reported  by  the  patients
Functional  dyspepsia  and  dyspepsia  associated  with  Helicobacte
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aFigure  1  Number  of  patients  with  Hp  infection  in  the  differ-
ent age  groups.
was  similar  in  both  groups  (43.2  months  in  the  patients
infected  with  Hp  vs  42.8  months  in  those  without  Hp,  p  =  NS).
The  group  of  cases  infected  with  the  bacterium  had  a
higher  mean  age  (48.08  years  in  the  patients  with  Hp  infec-
tion  vs  42.46  years  in  those  without  Hp).  There  were  a
b
e
c
(
Table  1  General  demographic  characteristics,  family  history,  and
With  Hp
n =  336  
Women,  n  (%) 247  (73.
Patients ≥  50  years  of  age,  n  (%) 150  (44.
FH of  gastric  cancer,  n  (%) 13  (3.9)
FH of  colorectal  cancer,  n  (%) 6  (1.8)
FH of  gallstones,  n  (%) 20  (5.9)
FH of  diverticular  disease,  n  (%) 5  (1.4)
FH of  functional  gastrointestinal  disorder,  n  (%) 37  (11)  
Smoking n  (%)  
Negative 266  (79.
Current 40  (11.9
In the  past  30  (8.9)
Alcoholic  beverage  consumption,  n  (%)  
Negative 245  (72.
Current 82  (24.4
In the  past  9  (2.7)  
History of  abdominal  surgeries,  n  (%)  114  (33.
Cholecystectomy  46  (13.7
Appendectomy  35  (10.4
Hysterectomy  43  (12.8
Others 23  (6.8)
Two abdominal  surgeries 19  (5.7)
Three or  more  abdominal  surgeries 11  (3.3)
Esthetic  surgeries,  n  (%)  26  (7.7)
Personal history  of  drug  allergy,  n  (%)  39  (16.1
FH: Family history.r  pylori  infection  129
reater  number  of  patients  50  years  old,  or  older,  in  the
p  group  compared  with  the  non-Hp  group  (44.6  vs  31.4%
espectively,  p  =  0.0006,  RR  1.25  [1.09-1.43]).  Hp  infection
revalence  rose  as  patient  age  increased  (ﬁg.  1).  The  preva-
ence  of  Hp  infection  in  patients  under  29  years  of  age  was
4%,  it  was  55%  in  the  group  between  30  and  39  years  of
ge,  58%  in  those  between  the  ages  of  40  and  49  years,
1%  in  the  patients  between  50  and  59  years  of  age,  67%
n  those  between  the  ages  of  60  and  69  years,  and  73%
n  the  patients  over  70  years  of  age.  No  signiﬁcant  dif-
erences  were  observed  between  the  groups  in  relation
o  distribution  by  sex,  the  prevalence  of  a  family  history
f  known  functional  and  organic  gastrointestinal  diseases,
moking,  alcohol  consumption,  a  personal  history  of  abdom-
nal  surgeries,  esthetic  surgeries,  or  a  history  of  allergies
Table  1).
There  was  a  greater  frequency  in  the  Hp  group  of
verweight,  obesity,  high  blood  pressure,  and  diabetes  mel-
itus  (Table  2).  The  prevalence  of  metabolic  syndrome  was
reater  in  the  Hp  group  compared  with  the  non-Hp  group
5.7%  vs  2.5%,  respectively,  p  =  0.04).  However,  all  these  dif-
erences  disappeared  when  the  analysis  was  paired  by  age
nd  sex  (Table  3).  No  signiﬁcant  differences  were  observed
etween  the  groups  in  relation  to  hospital  admissions,
mergency  department  visits,  psychiatric  attention,  or  psy-
hotropic  drug  use  in  the  year  prior  to  the  endoscopy  study
Table  2).
 non-pathologic  personal  history.
 infection  Without  Hp  infection p  value
n  =  242
51)  186  (76.8%)  0.1
6) 76  (31.4)  0.0006
 6  (2.5)  0.2
3  (1.2)  0.3
16  (6.6) 0.4
6  (2.5) 0.2
38  (15.8)  0.5
0.3
1)  188  (77.7)
)  42  (17.3)
 12  (4.9)
0.1
9)  167  (69.0)
)  69  (28.5)
6  (2.5)
9)  70  (29.0)  0.1
)  28  (11.6)
)  26  (10.8)
)  16  (6.6)
 14  (5.8)
18  (7.4)
 5  (3)
 13  (5.4)  0.1
)  40  (11.9)  0.06
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Table  2  Prevalence  of  associated  comorbidities,  pathologic  personal  history,  medical  service  use,  and  medication  consumption.
With  Hp  infection  Without  Hp  infection p  value
n =  336  n  =  242
High  blood  pressure  72  27  0.0005*
Diabetes  mellitus  35  9  0.001*
Dyslipidemias  39  25  0.3
Hypothyroidism  24  15  0.3
Metabolic syndrome  19  6  0.04*
Abdominal  surgeries  114  70  0.1
Cholecystectomy  46  28
Appendectomy  35  26
Hysterectomy  43  16
Others 23  14
History of  two  surgeries  19  18
Three or  more  surgeries  11  5
Esthetic surgeries 26  13  0.1
Hospitalizations  the  previous  year 12  7  0.4
Emergencies  the  previous  year 25  29  0.2
Psychiatric attention 42  41  0.08
Psychotropic  drug  use 99  73  0.4
Allergies 39  40  0.1
Current medications 141  92  0.1
* Signiﬁcant p value.
Table  3  Analysis  of  the  prevalence  of  comorbidities  and  dyspeptic  syndromes  paired  by  age  and  sex  (1:1).
With  Hp  infection  Without  Hp  infection p  value
n =  215  n  =  215
High  blood  pressure,  n  (%)  32  (14.9)  26(12.1)  0.2
Diabetes mellitus,  n  (%)  19  (8.8)  9  (4.2)  0.5
Metabolic syndrome,  n  (%)  10  (4.7)  6  (2.8)  0.4
Obesity, n  (%)  31  (14.4)  25  (11.6)  0.4
Overweight, n  (%)  74  (34.4)  72  (33.5)  0.9
Overweight and  obesity,  n  (%)  105  (48.8)  97  (45.1)  0.4
Epigastric pain  syndrome,  n  (%)  129  (60.0)  115  (53.5)  0.2
Postprandial  distress  syndrome,  n  (%)  38  (17.7)  31  (14.4)  0.4
Overlap of  both  syndromes,  n  (%)  48  (22.3)  69  (32.1)  0.03*
* Signiﬁcant p value.
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(Upon  individual  symptom  evaluation,  there  was  no  dif-
erence  between  the  groups  in  regard  to  the  prevalence
f  epigastric  pain,  epigastric  burning  sensation,  burping,  or
loating,  even  though  the  patients  with  Hp  presented  less
requently  with  fullness,  early  satiety,  and  nausea  compared
ith  the  non-Hp  patients  (Table  4).  In  the  analysis  of  the  pre-
ominant  symptoms  together,  there  was  a  greater  frequency
f  epigastric  pain  syndrome  between  the  patients  infected
ith  the  bacterium  compared  with  those  not  infected  (64.6
s  54.4%,  respectively,  p  =  0.01,  RR  1.51,  95%  CI  1.08-2.13),
he  prevalence  of  postprandial  distress  syndrome  was  simi-
ar  in  the  two  groups  (16.1%  cases  vs  14.9%  controls,  p  =  NS),
nd  there  was  a  greater  number  of  subjects  in  the  non-Hp
roup  that  presented  with  overlap  of  both  syndromes  (19.3%
f  the  cases  vs  30.6%  of  the  controls,  p  =  0.002)  (Table  4).
t
6
u
cevertheless,  the  analysis  paired  by  age  and  sex  showed  a
imilar  prevalence  between  the  groups  in  relation  to  epi-
astric  pain  syndrome  (60%  with  Hp  vs  53.5%  without  Hp,
 = NS)  and  postprandial  distress  syndrome  (17.7%  with  Hp
s  14.4%  without  Hp,  p  =  NS).  There  was  a  higher  number  of
verlap  of  both  syndromes  in  the  non-Hp  group  (22.3%  with
p  vs  32.1%  without  Hp,  p  =  0.03,  OR  0.6,  95%  CI  =  0.39-0.93)
Table  3).
The  endoscopic  ﬁndings  were  similar  in  the  two  groups.
iatal  hernia  was  detected  in  11  cases  and  in  14  controls
3.3%  vs  5.8%,  respectively,  p  =  NS),  diminutive  hyperplas-
ic  gastric  polyps  in  13  cases  and  16  controls  (3.9%  vs
.6%  respectively,  p  =  NS),  and  a  duodenal  submucosal  nod-
le  in  one  case  and  duodenal  lymphangiectasia  in  one
ontrol.
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Table  4  Prevalence  of  dyspeptic  symptoms  and  syndromes.
With  Hp  infection  Without  Hp  infection p  value
N =  336  N  =  242
Individual  symptoms
Epigastric  pain  285  195  0.09
Epigastric burning  207  159  0.17
Fullness 107  105  0.003*
Satiety  116  109  0.006*
Burping  129  108  0.07
Nausea 140  120  0.03*
Bloating  141  121  0.03*
Dyspeptic  syndromes
Epigastric  pain  syndrome 217  132  0.007*
Postprandial  distress  syndrome  54  36  0.39
Overlap syndrome  65  74  0.001*
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Discussion
The  present  study  shows  that  the  clinical  characteristics  in
the  patients  with  FD  infected  with  Hp  were  similar  to  those
of  non-infected  patients,  and  therefore  they  could  not  be
differentiated  or  identiﬁed  a  priori. Our  study  also  found  a
prevalence  of  Hp  infection  in  patients  with  FD  of  58%  that
increased  with  patient  age.
Functional  gastrointestinal  disorders  are  deﬁned  by  the
absence  of  organic,  metabolic,  or  systemic  diseases  that
explain  their  symptoms.  One  notable  exception  to  this  rule
is  Hp  infection  that  is  included  in  FD  according  to  the  Rome
III  criteria  despite  the  fact  that  it  causes  motor,  secretory,
and  inﬂammatory  disorders.10 Thus,  the  term  ‘‘functional’’
has  been  questioned  in  reference  to  dyspepsia  associated
with  Hp  infection.11 On  the  other  hand,  the  eradication  of
the  bacterium  has  been  shown  to  be  effective  treatment
in  at  least  one  subgroup  of  patients  with  dyspepsia,13 and
therefore  the  clinical  identiﬁcation  of  those  patients  with
Hp  infection  could  enable  the  deﬁnition  of  groups  that  would
beneﬁt  from  speciﬁc  treatments.
It  has  been  inferred  that  the  inﬂammation  produced  by
the  bacterium  can  cause  pain,  and  its  presence  and  inten-
sity  could  be  an  indicator  of  infection.  Tucci  et  al.  found
that  epigastric  pain  and  burning  sensation  were  signiﬁcantly
more  intense  in  patients  with  dyspepsia  infected  with  the
bacterium  than  in  those  not  infected.14 However,  the  rela-
tion  is  not  solid,  given  that  some  studies  have  reported  an
association  between  the  grade  of  inﬂammation  and  pain
intensity,15,16 but  others  have  not  been  able  to  establish
any  correlation.17,18 Similarly,  several  studies  have  demon-
strated  that  the  bacterium  induces  motility  and  gastric
emptying  disorders,  but  these  changes  have  not  resulted  in
speciﬁc  or  distinctive  symptom  patterns.19--21 In  the  present
study,  the  initial  data  analysis  showed  that  a  greater  number
of  patients  with  dyspepsia  infected  with  the  bacterium  had
epigastric  pain  syndrome,  but  this  difference  was  nulliﬁed
when  the  sub-analysis  paired  by  age  and  sex  was  carried  out.
If  patients  with  dyspepsia  and  Hp  infection  cannot  be
identiﬁed  through  symptoms,  then  other  factors  should
be  explored.  The  initial  analysis  of  our  study  showed  a
b
s
t
dreater  prevalence  of  overweight,  obesity,  high  blood  pres-
ure,  diabetes  mellitus,  and  metabolic  syndrome  in  the
atients  with  dyspepsia  infected  with  the  bacterium.  Some
tudies  have  found  that  this  bacterium  plays  an  impor-
ant  role  in  cardiometabolic  disorders  and  its  presence  has
ecently  been  signiﬁcantly  and  consistently  associated  with
 higher  body  mass  index,  overweight,  and  obesity  in  a  Chi-
ese  population.22,23 Nevertheless,  this  relation  is  not  clear,
iven  that  other  studies  have  shown  an  inverse  relation
etween  infection  with  the  bacterium  and  prevalence  of
verweight  and  obesity  in  both  children  and  adults  in  devel-
ped  countries.24,25 Likewise,  the  effects  of  the  bacterium
n  ghrelin  secretion  have  not  been  completely  explained.
his  peptide,  which  regulates  appetite  and  body  weight,
as  been  found  to  be  suppressed  in  patients  with  chronic
p  infection26 and  its  levels  in  plasma  have  increased  with
he  microorganism’s  erradication,27 whereas  other  studies
ave  not  found  signiﬁcant  changes  in  the  serum  levels  of
he  peptide  in  relation  to  active  infection  or  the  eradication
f  the  bacterium.28 Even  if  the  presence  of  cardiometabolic
isorders  were  a  biomarker  of  dyspepsia  due  to  Hp,  the
ub-analysis  paired  by  age  and  sex  in  the  present  study  did
ot  conﬁrm  an  association  between  the  two  factors.  It  is
ost  likely  that  the  association  found  was  a  product  of  bias,
iven  that  in  the  infected  group  the  mean  age  and  the  num-
er  of  patients  older  than  50  years  of  age  was  signiﬁcantly
igher.
Due  to  the  fact  that  functional  dyspepsia  is  related  to  psy-
hologic  factors  and  psychiatric  comorbidity,29,30 it  is  valid
o  think  that  dyspepsia  not  associated  with  Hp  infection
ould  have  a  greater  relation  to  these  factors  because  it  is
 clearly  functional  disease.  One  study  that  investigated  the
resence  of  psychologic  factors  in  patients  with  functional
yspepsia  compared  with  patients  with  peptic  ulcer  found
hat  functional  dyspepsia  patients  had  more  severe  psycho-
ogic  comorbidity  and  psychiatric  disorders  than  those  with
rganic  disease.31 In  our  study  there  were  no  differences
etween  the  groups  in  relation  to  a  history  of  abdominal
urgeries,  esthetic  surgeries,  the  need  for  medical  atten-
ion  at  the  emergency  department,  the  use  of  psychotropic
rugs,  or  psychiatric  attention  that  could  be  indicative  of
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10. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel
disorders. In: Drossman DA, editor. Rome III. The functional32  
ssociated  psychologic-psychiatric  comorbidity  and  somati-
ation.  Nor  were  these  characteristics  useful  for  inferring
he  absence  or  presence  of  the  bacterium.
An  interesting  ﬁnding  of  our  study  was  that  the  preva-
ence  of  Hp  infection  rose  as  patient  age  increased.  One
ossible  explanation  of  this  fact  could  be  the  epidemiologic
hange  observed  worldwide  in  recent  years.  A  systematic
eview  of  the  epidemiology  of  this  infection  in  Iran  and
ountries  to  the  east  of  the  Mediterranean  found  that  posi-
ive  serology  for  the  most  virulent  Hp  (Cag  A  +  )  was  greater
s  the  age  of  the  study  populations  increased.32 A  lower
revalence  of  Hp  has  also  been  found  in  the  younger  genera-
ions,  suggesting  that  the  prevalence  of  the  infection  could
ecline  in  the  future.33 This  ﬁnding  should  be  investigated
ore  appropriately  in  the  future.  Our  study  design  did  not
llow  us  to  make  conclusions  about  it.
In  the  present  study,  we  compared  two  well-deﬁned
roups  of  subjects,  the  Hp-infected  group  and  the  non-Hp
roup,  examining  a  wide  variety  of  clinical  characteristics
n  search  of  an  objective  indicator  that  would  predict  the
resence  of  the  bacterium.  The  number  of  cases  included
n  the  study  allowed  a  sub-analysis  paired  by  age  and  sex  to
e  carried  out,  but  since  there  was  no  calculation  from  a
revious  sample,  we  could  not  be  certain  that  the  absolute
umber  obtained  was  sufﬁcient  for  determining  differences.
he  diagnostic  methods  were  the  same  for  the  entire  group
nd  the  same  physician  performed  the  endoscopic  exami-
ations,  strengthening  our  study.  Concomitantly,  we  were
ble  to  know  the  prevalence  of  the  infection  in  patients
ith  dyspeptic  symptoms  and  no  erosive,  ulcerous,  or  neo-
lastic  lesions  of  the  proximal  digestive  tract.  Nevertheless,
his  study  has  the  methodological  defects  inherent  in  all
etrospective  studies  of  not  having  used  validated  instru-
ents  for  detecting  and  determining  digestive  symptom
ntensity  or  conﬁrming  the  presence  or  absence  of  infec-
ion  through  more  than  one  diagnostic  method.  Given  that
here  is  no  ideal  diagnostic  test  for  determining  the  pres-
nce  of  Hp,  the  combining  of  the  results  of  2  or  more  tests
an  be  a  reasonable  diagnostic  strategy  for  obtaining  more
eliable  results.34,35 In  the  present  study,  the  diagnosis  of
nfection  was  made  only  through  the  use  of  a  commer-
ial  urease  test.  If  properly  used,  this  type  of  test  has
5-100%  sensitivity  and  85-95%  speciﬁcity.34,35 The  urease
est  that  we  employed  was  validated  in  a  Mexican  popu-
ation  and  compared  with  another  rapid  urease  test  and
istology,  and  its  diagnostic  performance  was  adequate.36
n  addition,  performing  the  rapid  urease  test  utilizing  2  gas-
ric  biopsies  (one  from  the  body  and  the  other  from  the
ntrum),  which  was  done  in  our  study,  can  improve  the
ccuracy  of  the  test  by  reducing  the  sampling  error  result-
ng  from  the  non-uniform  distribution  of  the  bacterium  in
he  stomach.34 Therefore,  we  consider  that  better  designed
rospective  studies  are  required  for  detecting  clinical  char-
cteristics  in  patients  with  dyspepsia  that  would  enable  the
resence  of  the  infection  to  be  predicted  and  identiﬁed
 priori.
In conclusion,  this  study  showed  that  the  patients  with  FD
nfected  with  Hp  had  similar  clinical  characteristics  to  those
atients  that  were  not  infected,  and  thus  they  could  not
e  differentiated  a  priori. There  was  also  a  58%  prevalence
f  Hp  infection  in  patients  with  FD  and  the  infection  was
bserved  to  increase  with  patient  age.J.L.  Rodríguez-García,  R.  Carmona-Sánchez
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